2025-07-05 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided, formatted as a concise English report:

## Albemarle Corp (ALB) Stock Analysis

Albemarle Corp (ALB) is a specialty chemicals manufacturing company with a focus on lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 11.72%
*   **VOO (S&P 500) Cumulative Return:** 95.42%
*   **Spread:** -87.1 (Relative Spread: 1.7)
*   **Analysis:** ALB has significantly underperformed the S&P 500. The large negative spread and low relative spread indicate substantial underperformance compared to the benchmark. The relative spread of 1.7 means that the current underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2015-2017  | 99.0%    | 8.1%     | 70.0%    | 0.0    | 15.1   |
| 2016-2018  | 13.0%    | 58.0%    | -5.0%    | 0.0    | 9.1    |
| 2017-2019  | -44.0%   | 58.0%    | -74.0%   | -0.0   | 8.6    |
| 2018-2020  | 101.0%   | 62.9%    | 81.0%    | 0.6    | 17.4   |
| 2019-2021  | 268.0%   | 62.9%    | 220.0%   | 0.6    | 27.5   |
| 2020-2022  | 239.0%   | 75.6%    | 237.0%   | 0.8    | 25.5   |
| 2021-2023  | -53.0%   | 77.5%    | -71.0%   | 0.6    | 17.0   |
| 2022-2024  | -200.0%  | 77.5%    | -225.0%  | 0.7    | 10.1   |
| 2023-2025  | -336.0%  | 77.5%    | -384.0%  | 3.0    | 7.9    |

**Analysis:** The table reveals fluctuating performance over different periods. Recent years (2021-2025) show significant negative CAGR and Alpha, indicating underperformance and value destruction. High Maximum Drawdown (MDD) across all periods suggests considerable volatility. The Beta values vary, with the most recent period showing a notably high Beta of 3.0, indicating high sensitivity to market movements. The Cap(B) values show a decline in market capitalization, reflecting the recent poor performance.

### 2. Recent Price Action

*   **Current Price:** $67.21
*   **Previous Close:** $67.99
*   **Change:** -1.15 (-1.7%)
*   **5-Day Moving Average:** 65.06
*   **20-Day Moving Average:** 61.87
*   **60-Day Moving Average:** 58.95

**Analysis:** The stock price has decreased slightly compared to the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend, but the recent negative change warrants caution.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 60.67
*   **PPO:** 1.17
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** 1.7 (+) indicating a short-term increase
*   **Expected Return (%):** 7309.6%

**Analysis:** The MRI indicates low market risk. The RSI is slightly above 50, suggesting moderate buying pressure, but not yet overbought. The PPO is positive, signaling a potential upward trend. The hybrid signal advises a cautious approach, recommending buying a portion of the available cash. A positive recent relative spread change aligns with a short-term increase. A high expected return suggests substantial long-term potential exceeding the S&P 500. The price change of -1.7% indicates a decrease, but it's not drastic enough to signal a significant short-term issue.

### 4. Recent News & Significant Events

*   **[2025-07-04]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-05]:** Analyst discussions on recent performance and outlook.
*   **[2025-07-02]:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-01]:** Market experts highlight risks and opportunities.

**Analysis:** Recent news indicates significant activity and volatility around Albemarle. Investors should closely monitor company announcements and industry trends.

### 5. Recent Earnings Analysis

| 날짜       | EPS     | 매출       |
|------------|---------|------------|
| 2025-04-30 | 0       | 1.08 B$    |
| 2024-11-06 | -9.45   | 1.35 B$    |
| 2024-07-31 | -1.96   | 1.43 B$    |
| 2024-05-01 | -0.08   | 1.36 B$    |
| 2025-04-30 | -0.08   | 1.36 B$    |

**Analysis:** Earnings per share (EPS) has been inconsistent, with a significant loss reported in Q4 2024. Revenue has also fluctuated, showing a recent decrease.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $1.08B   | 14.51%        |
| 2024-12-31 | $1.23B   | 11.22%        |
| 2024-09-30 | $1.35B   | -7.68%        |
| 2024-06-30 | $1.43B   | -0.74%        |
| 2024-03-31 | $1.36B   | 2.86%         |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
|------------|----------|-----------|
| 2025-03-31 | $10.03B  | 0.41%     |
| 2024-12-31 | $9.96B   | 0.76%     |
| 2024-09-30 | $10.24B  | -10.44%    |
| 2024-06-30 | $11.22B  | -1.68%    |
| 2024-03-31 | $11.53B  | 0.02%     |

**Analysis:** Revenue has declined from Q2 2024 to Q1 2025, and profitability has been inconsistent, with negative profit margins in some quarters. Equity has also decreased, and ROE has been low or negative, indicating poor returns on equity.

### 7. Overall Analysis

Albemarle (ALB) has significantly underperformed the S&P 500. Recent earnings and financial data reveal inconsistent profitability, declining revenue, and low returns on equity. Recent news suggests volatility and significant events impacting the company. While technical indicators show a low market risk environment and some short-term upward movement, investors should exercise caution.
